Table 5.

Resource Utilization among Cancer Patients with Empiric Fluconazole Antifungal Therapy by Treatment Failure

	Treatment Failure	No Treatment Failure	Difference	P	R2
N	42	61
LOS, day
Unadjusted Mean (SE)	30.3 (1.9)	23.7 (1.5)	6.6	0.007
Median (range)	27 (8–73)	22 (4–55)	5.0
Adjusted Mean (SE) *	30.7 (1.6)	23.4 (1.3)	7.3	0.001	0.34
Total Costs per patient, $
Unadjusted Mean (SE)	71,122 (6,432)	55,234 (5,337)	15,888	0.060
Median (range)	56,924 (10,647–275,130)	47,642 (3,416–268,447)	9,282
Adjusted Mean (SE) *	72,921 (6,118)	53,996 (5,068)	18,925	0.020	0.18

LOS, length of stay; SE, standard error;

* Adjusted for age, gender, insurance status (uninsured or Medicaid), DRG weight and length of stay before empiric fluconazole therapy.